Article
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Cancer chemotherapy and pharmacology - 1 Sept 2010
Kim Seung Tae, Lee Jeeyun, Park Se Hoon, Park Joon Oh, Lim Ho Yeong, Kang Won Ki, Kim Jin Yong, Kim Young Ho, Chang Dong Kyung, Rhee Poong-Lyul, Kim Dae Shick, Yun Haeran, Cho Yong Beom, Kim Hee Cheol, Yun Seong Hyeon, Lee Woo Yong, Chun Ho-Kyung, Park Young Suk
Abstract excerpt
PURPOSE: Colon cancer with DNA mismatch repair (MMR) defects reveals indistinguishable clinical and pathologic aspects, including better prognosis and reduced response to 5-fluorouracil (5-FU)-based chemotherapy. There has been no consensus for p53 as a prognostic marker in colorectal cancer. This study investigated the clinical implication of MSI-H/MMR-D and p53 expression in R0-resected colon cancer patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
